Evidence map›Paper›PMID 42458902›Full record

ArticleArchiv der Pharmazie2026

Evaluation of Novel Cloxyquin Analogs for K

Jasmin Sörgel, Marcel Kloth, Henning Klaasen, Sven G Meuth, Thomas Budde, Bart Jan Ravoo, Julian A Schreiber

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archiv der Pharmazie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jasmin SörgelInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, NRW, Germany.
Marcel KlothOrganisch-Chemisches Institut, University of Münster, Münster, NRW, Germany.ORCID https://orcid.org/0009-0000-3737-2164
Henning KlaasenOrganisch-Chemisches Institut, University of Münster, Münster, NRW, Germany.ORCID https://orcid.org/0000-0002-1930-5969
Sven G MeuthDepartment of Neurology, University Hospital Münster, Münster, NRW, Germany.ORCID https://orcid.org/0000-0003-2571-3501
Thomas BuddeInstitute of Physiology, University of Münster, Münster, NRW, Germany.ORCID https://orcid.org/0000-0002-5263-8183
Bart Jan RavooOrganisch-Chemisches Institut, University of Münster, Münster, NRW, Germany.ORCID https://orcid.org/0000-0003-2202-7485
Julian A SchreiberInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, NRW, Germany.ORCID https://orcid.org/0000-0002-3847-7539

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

K

Indexed as

Potassium Channels, Tandem Pore DomainQuinolinesAnimalsChloroquinolinolsDose-Response Relationship, DrugHumansMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipChloroquinolinolscloxyquinPotassium Channels, Tandem Pore DomainQuinolines8‐hydroxyquinolinescloxyquinK2P18.1K2P channelsTRESK

Identifiers

PMID42458902
PMCPMC13373494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.